AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00618085 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motor imagery practice
Description: During motor imagery practice a person imagines performing a skill or movement with all its sensory consequences without actually moving. In this study the therapists follow a motor imagery guideline designed for rehabilitation of skills and movement performance in subjects with neurological disease or damage. The guideline offers therapists structure and a strategy to deliver subject-specific imagery. The guideline is based on three major frameworks, namely; principles of motor learning, phased process of human movement and a training guide for sports coaches and performers from the National Coaching Foundation.
Study NCT00618085 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard physiotherapy and occupational therapy
Description: Patients with neurological disease or damage will receive standard physiotherapy and occupational therapy.
Study NCT00946985 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paliperidone palmitate
Description: 50, 75, 100, or 150 mg eq. monthly injection for 2 years
Study NCT00946985 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: oral risperidone
Description: 2, 4, 6, or 8 mg tabs once daily for two years
Study NCT01775397 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fidaxomicin
Description: capsule
Study NCT01775397 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vancomycin
Description: capsule
Study NCT01775397 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Capsule
Study NCT00651729 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Botulinum Toxin Type A
Description: Each patient received from 1 to 5 treatments, with a minimum of 12 weeks between treatments. For each treatment, a total dose of 200 U to 400 U botulinum toxin Type A was injected into the wrist and finger flexor muscles of the affected upper limb, not to exceed 6 U/kg
Study NCT03922113 — intervention group
Intervention type: OTHER
Intervention: Patient follow up
Description: Patient follow up during one month
Study NCT00933777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination of sorafenib and everolimus
Description: Dose finding: Treatment with defined dose of sorafenib of 2x400 mg with increasing dose of everolimus (2.5 mg, 5 mg, 7.5 mg, 10 mg) Extension: Treatment with defined dose of sorafenib of 2x400 mg with everolimus 7.5 mg
Study NCT02670148 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Chiropractic manipulative therapy
Description: We will set an a priori treatment schedule of 8 visits at a frequency of 2 visits per week over a 4 week period. CC participants will receive chiropractic manipulative therapy (CMT). CMT procedures can be broadly divided into two types, thrust and non-thrust. Thrust CMT is a high-velocity low-amplitude procedure characterized by a single, short duration thrust (ranging from 100 to 500 ms) of low amplitude force applied to a target joint that often results in an audible sound, or cavitation. Non-thrust CMT employs low-velocity and often repeated joint movements of varying amplitude. In the event that no CMT treatment is clinically indicated, treatment will not be provided.
Study NCT04402255 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pilates exercise
Description: The key elements of Pilates during supine, prone, side-lying and standing positions will be taught. These key elements are: breathing (diaphragmatic), focusing (neutral position), rib cage placement, shoulder placement, head and neck placement (neutral position). Then, Pilates based 'mat' exercises will be performed by the physiotherapist in the clinic for 8 weeks, 2 days / week, 16 sessions. Each session will be programmed to be 45 minutes. During all exercises, including warm-up and cooling, patients will be asked to provide key elements and protect them during movements. Depending on the condition of the patients, the exercises will be advanced from easy to difficult.
Study NCT04402255 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: pilates exercise
Description: The key elements of Pilates during supine, prone, side-lying and standing positions will be taught. These key elements are: breathing (diaphragmatic), focusing (neutral position), rib cage placement, shoulder placement, head and neck placement (neutral position). Then, Pilates based 'mat' exercises will be performed by the physiotherapist in the clinic for 8 weeks, 2 days / week, 16 sessions. Each session will be programmed to be 45 minutes. During all exercises, including warm-up and cooling, patients will be asked to provide key elements and protect them during movements. Depending on the condition of the patients, the exercises will be advanced from easy to difficult.
Study NCT02831673 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC)
Description: Tenofovir disoproxil fumarate and Emtricitabine are available as swedish orange, 'AA' sized elongated double blind HPMC capsules containing 300 mg TDF and 200 mg FTC to visually match overencapsulated 3TC tablet. The capsules are packaged into HDPE bottles with induction seals and child resistant closures. Each 150 mL bottle contains 30 capsules and a desiccant. Overencapsulated tenofovir disoproxil fumarate/emtricitabine tablet will be orally administered once daily with or without food upto 96 weeks. From Week 96 to Week 148, tenofovir disoproxil fumarate/emtricitabine will be dispensed as 300/200 mg white, blue, capsule shaped, film coated tablets debossed with 'GILEAD' on one side and '701' on another side, packed in overlabelled HDPE bottles with polypropylene childresistant closures each containing 30 tablets and a desiccant.
Study NCT03047980 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sirolimus
Description: Low dose oral sirolimus
Study NCT02488863 — intervention group
Intervention type: OTHER
Intervention: MRI Neuroimaging
Description: MRI scans utilized to measure the structural and functional integrity of the brain.
Study NCT02488863 — intervention group
Intervention type: OTHER
Intervention: Quantitative Sensory Testing
Description: Vibratory Detection Thresholds; Tactile Detection Thresholds; Thermal Detection Thresholds, Pain Thresholds, and Temporal Summation; Allodynia and Temporal Summation; Punctate Pain Testing and Temporal Summation; and Pressure Pain Thresholds.
Study NCT02488863 — intervention group
Intervention type: OTHER
Intervention: Questionnaires
Description: The Modified Mini-Mental State Examination (3MS), the Montreal Cognitive Assessment (MoCA), the Center for Epidemiologic Studies Depression Scale (CES-D), the Geriatric Depression Scale (GDS), the Edinburg Handedness Inventory, the Ten-Item Personality Inventory (TIPI), the Pittsburgh Sleep Quality Index (PSQI), the state and trait versions of the State-Trait Anxiety Inventory (STAI), the state and trait versions of the Positive and Negative Affect Schedule (PANAS), pain questionnaires (the Graded Chronic Pain Scale (GCPS), the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Pain-Detect, the short-form McGill Pain Questionnaire (SF-MPQ-2), and the Coping Strategies Questionnaire-Revised (CSQ-R)), a standardized paper and pencil cognitive battery (Hopkins Verbal Learning Test (HVLT), Trail Making A\&B, Boston Naming Test, Controlled Oral Word Association Test (COWAT), Stroop Interference Test, Ruff Figural Fluency Test, and Raven's Progressive Matrices Test).
Study NCT02488863 — intervention group
Intervention type: OTHER
Intervention: Physical and Cognitive Function Testing
Description: Upper Limb Isometric Strength, Short Physical Performance Battery (SPPB), GAITRite Instrumented Walking, Galvanic Skin Response, Knee Extension Isokinetic Strength, the Pepper Assessment Tool for Disability (PAT-D), and an electronic NIH Toolbox Cognitive Battery.
Study NCT02364128 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Decider Guider: Weight Loss
Description: Decision aid tool about weight loss treatment
Study NCT00874120 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenylephrine Hydrochloride (HCl) Extended-Release tablets 30 mg
Description: Phenylephrine HCl Extended-Release tablets 30 mg taken twice daily (12 hours apart) for 7 days.
Study NCT00874120 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo taken twice daily (12 hours apart) for 7 days.
Study NCT02187952 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral feeding intervention
Description: Behavioral feeding intervention will include escape extinction.
Study NCT03331809 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Two-handed jaw thrust
Description: The assistant applied two-handed jaw thrust when intubating with double-lumen tube endotracheal tube.
Study NCT03331809 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional intubation
Description: The attending anesthesiologist provided intubation with double-lumen tube endotracheal tube without two-handed jaw thrust.
Study NCT04395261 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Wideband Tympanometry
Study NCT03894397 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Electrical stimulation of the BNST
Description: Electrical stimulation of the BNST
Study NCT03894397 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrical stimulation of the BNST
Description: Electrical stimulation of the BNST
Study NCT01301898 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GC1111_0.5mg/kg
Study NCT01301898 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GC1111_1.0mg/kg
Study NCT01301898 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Elaprase_0.5mg/kg
Study NCT02470000 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Intravascular laser irradiation of blood (ILIB)
Description: continuous-wave ILIB is performed using a 632.8nm (red light) laser beam from a He-Ne laser machine (Y-J ILIB-5, Bio Human Energy Cooperation, New Taipei City, Taiwan, R.O.C.).The participants sit on a sofa with their arms relax and supported on the table. A 24-gauge catheter is inserted to a superficial vein in upper extremity under sterile preparation, and an optic fiber channel is connected to the catheter for blood irradiation.
Study NCT02470000 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intravascular laser irradiation of blood (ILIB)
Description: continuous-wave ILIB is performed using a 632.8nm (red light) laser beam from a He-Ne laser machine (Y-J ILIB-5, Bio Human Energy Cooperation, New Taipei City, Taiwan, R.O.C.).The participants sit on a sofa with their arms relax and supported on the table. A 24-gauge catheter is inserted to a superficial vein in upper extremity under sterile preparation, and an optic fiber channel is connected to the catheter for blood irradiation.
Study NCT02470000 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation
Description: TENS over neck for 15 minutes.
Study NCT02470000 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation
Description: TENS over neck for 15 minutes.
Study NCT02470000 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Stretching exercise
Description: stretching exercise to the involved muscle for 15 minutes.
Study NCT02470000 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stretching exercise
Description: stretching exercise to the involved muscle for 15 minutes.
Study NCT01572987 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Radiofrequency Ablation(RFA) by HALO device.
Description: RFA or Surveillance every 2 months for 1 year.
Study NCT01572987 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic mucosal resection(EMR) by mucosectomy kit.
Description: EMR or surveillance every 2 months.
Study NCT04027478 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: FMD
Description: fasting mimicking diet
Study NCT04001959 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Silver Diamine Fluoride with Potassium Iodide
Description: Dry the tooth for 30 seconds with air jet and apply one drop of Diamino 30% Silver Fluoride with a disposable applicator brush for 3 minutes and one drop of potassium iodide solution immediately on the treated surface, then wash.
Study NCT04001959 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Silver Diamine Fluoride with Potassium Iodide
Description: Dry the tooth for 30 seconds with air jet and apply one drop of Diamino 30% Silver Fluoride with a disposable applicator brush for 3 minutes and one drop of potassium iodide solution immediately on the treated surface, then wash.
Study NCT03815318 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant Human Coagulation FVIII
Description: Participant received SCT800 for prophylaxis with 25 - 50 IU/kg injection once every other day or three times per week for 6 months.
Study NCT04388462 — intervention group
Intervention type: OTHER
Intervention: Finite element analysis
Description: Biomechanical study to describe micromotion
Study NCT00527241 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Raices nuevas
Description: 8 90-minute sessions (once a week) of problem-posing and facilitated discussion on respect, anger, support, trust, negotiating, partnership with your intimate partner.
Study NCT02921334 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: switching between invasive and noninvasive ventilation
Description: As defined criteria, patients are switched between invasive and noninvasive ventilation until the ventilator is successfully weaned.
Study NCT00933556 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: VSL#3
Description: 6 gms of powder formulation to be given once a day for 4 weeks
Study NCT00933556 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: sugar pill (placebo)
Description: placebo identical to the active product will be given
Study NCT03844204 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Thermal servo-controlled system
Description: All patients will be positioned under the infant warmer. In the treatment group, a probe positioned on the skin of the neonate will guide the thermal exposure in a servo-controlled modality. In the control group, thermal exposure will be determined manually by setting the power of the heater at the maximum output.
Study NCT03844204 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Thermal servo-controlled system
Description: All patients will be positioned under the infant warmer. In the treatment group, a probe positioned on the skin of the neonate will guide the thermal exposure in a servo-controlled modality. In the control group, thermal exposure will be determined manually by setting the power of the heater at the maximum output.
Study NCT04075253 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: VO2 peak testing
Description: Exercise on treadmill starts with \~4km/h at 0% inclination before inclination is increased to 4% and speed kept unchanged. Inclination will then be increased with two percent approximately after each minute until exhaustion.
Study NCT01014910 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Continuous pulse oximetry monitoring
Description: Placement of a pulse oximeter to monitor oxygenation status. This is usually placed on a toe, finger, or ear lobe and held in place with adhesive tape. Patients will receive continuous pulse oximetry monitoring throughout their hospital stay regardless of their need for supplemental oxygen.
Study NCT01014910 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intermittent pulse oximetry monitoring
Description: Placement of a pulse oximeter to monitor oxygenation status. This is usually placed on a toe, finger, or ear lobe and held in place with adhesive tape. Patients will receive pulse oximetry monitoring during vital signs checks (every 4 hours) and as indicated clinically when not on supplemental oxygen. When patients require supplemental oxygen they will be continuously monitored by pulse oximetry until their oxygen requirement has resolved.
Study NCT02445794 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low dose cohort
Description: RT001 is encapsulated di-deutero synthetic homologue of linoleic acid ethyl ester. Each capsule contains 900 mg of RT001.
Study NCT02445794 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High dose cohort
Description: RT001 comparator is encapsulated non-deuterated linoleic acid ethyl ester.
Study NCT01146587 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GangTrainer GT1
Description: 30 minutes of treatment on the GangTrainer GT1 and 30 minutes of Conventional Physiotherapy every workday for 8 weeks
Study NCT01146587 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lokomat
Description: 30 minutes of treatment on the Lokomat and 30 minutes of Conventional Physiotherapy every workday for 8 weeks
Study NCT01146587 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physiotherapy
Description: 60 minutes of Conventional Physiotherapy every workday for 8 weeks
Study NCT02975557 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Brimonidine 0.15%
Description: Brimonidine 0.15% eye drops 2 times a day for 12 weeks
Study NCT02975557 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Brimonidine 0.075%
Description: Brimonidine 0.075% (1:1 dilution will be performed using 0.15% Alphagan-P solution with Refresh Plus Artificial Tears solution) eye drops 2 times a day for 12 weeks.
Study NCT02975557 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo (Refresh plus Artificial Tear) dispensed in Brimonidine bottles 2 times a day for 12 weeks.
Study NCT01895478 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PACCI-ED use
Description: Attending physicians were allowed to view the patient's PACCI-ED prior to completing the assessment form. Attendings were told at the time of the child's ED visit that the PACCI-ED is used to assess a child's asthma control and medication adherence, and that they could use it to complete the outcomes assessment form.
Study NCT02724397 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: LCI/BLI then white endoscopy
Description: First use of Linked Color Imaging/Magnifying Blue Laser Imaging (LCI/BLI) and then White Light Endoscopy to detect colonic adenomas.
Study NCT02724397 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: White endoscopy and then LCI/BLI
Description: First use of White Light Endoscopy and then Linked Color Imaging/Magnifying Blue Laser Imaging (LCI/BLI) to detect colonic adenomas.
Study NCT02037555 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AT-III (Human)
Description: AT-III (Human) is an antithrombin concentrate prepared from pooled human plasma. AT-III (Human) is provided as a freeze-dried preparation for intravenous use. The AT-III (Human) preparation is reconstituted in 10 or 20 mL of sterile water for injection prior to intravenous administration.
Study NCT02037555 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% Sodium Chloride for Injection, United States Pharmacopeia
Study NCT00600977 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Doxorubicine
Description: 9mg/m² J1 J4 2 COURSES
Study NCT00600977 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicine pegylated
Description: 40 MG/M² J1 2 courses
Study NCT03050229 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Description: Empagliflozin 10mg/day once daily before or after breakfast
Study NCT03050229 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo once daily before or after breakfast
Study NCT02237222 — intervention group
Intervention type: OTHER
Intervention: Gait rehabilitation
Study NCT00612807 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Weekly marital therapy
Description: Weekly marital therapy for 6 months.
Study NCT00612807 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: As indicated: Sertraline, bupropion, venlafaxine, mirtazepine, nortriptyline, tranylcypromine, lithium augmentation, etc.
Description: Study doctor may prescribe antidepressant medication for the treatment of depression. Medications will be prescribed according to empirically supported guidelines outlined in the Duke Somatic Treatment Algorithm for Geriatric Depression (STAGED Approach; Steffens, 2002).~SSRIs (daily dose of at least 20 mg for citalopram, 20 mg for fluoxetine, 100 mg for sertraline, 20 mg for paroxetine)~SNRIs (e.g., venlafaxine)~Bupropion SR (achieve dose of at least 150 mg BID)~Mirtazapine~Tricyclic antidepressants (nortriptyline with drug levels 80-120 ng/dl)~Lithium augmentation~MAOI (daily dose of at least 30 mg tranylcypromine or 45 mg of phenelzine)
Study NCT00612807 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: As indicated: Sertraline, bupropion, venlafaxine, mirtazepine, nortriptyline, tranylcypromine, lithium augmentation, etc.
Description: Study doctor may prescribe antidepressant medication for the treatment of depression. Medications will be prescribed according to empirically supported guidelines outlined in the Duke Somatic Treatment Algorithm for Geriatric Depression (STAGED Approach; Steffens, 2002).~SSRIs (daily dose of at least 20 mg for citalopram, 20 mg for fluoxetine, 100 mg for sertraline, 20 mg for paroxetine)~SNRIs (e.g., venlafaxine)~Bupropion SR (achieve dose of at least 150 mg BID)~Mirtazapine~Tricyclic antidepressants (nortriptyline with drug levels 80-120 ng/dl)~Lithium augmentation~MAOI (daily dose of at least 30 mg tranylcypromine or 45 mg of phenelzine)
Study NCT00849095 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: budesonide/formoterol combination (PRN)
Description: budesonide/formoterol combination 160/4.5 mcg 1 inhalation used as needed for a period of 52 weeks